Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody
Edward B Reilly, Andrew C Phillips, Fritz G Buchanan, Gillian Kingsbury, Yumin Zhang, Jonathan A Meulbroek, Todd B Cole, Peter J DeVries, Hugh D Falls, Christine Beam, Jinming Gu, Enrico L Digiammarino, Joann P Palma, Cherrie K Donawho, Neal C Goodwin, Andrew M Scott
Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2015
N.C. Goodwin is the Vice President of Champions Oncology, Inc. A.M. Scott reports receiving commercial research support from AbbVie and has ownership interest (including patents) in the Ludwig Institute for Cancer Research. No potential conflicts of interest were disclosed by the other authors.